Advancing Laboratory Diagnostics Through Collaboration

On 26 September 2025, the city of Šibenik hosted the conference “MLD: From Vision to Reality – Transformation of Laboratory Diagnostics.”
The event gathered members of the MLD Chamber, healthcare professionals and representatives of the academic community.
It focused on modern laboratory diagnostics and their growing role in personalised medicine.

During the conference, several experts presented research closely linked to the InnoThyroGene project, highlighting its clinical relevance and scientific potential.

Scientific Programme Featuring InnoThyroGene

The programme included three complementary presentations that addressed genetics, clinical practice and pharmacotherapy in thyroid diseases.
Together, they offered a comprehensive overview of current challenges and emerging solutions in the field.

Firstly, Prof. Tatijana Zemunik (MEFST) delivered an invited lecture titled “What Controls Our Thyroid – Genetics and/or the Environment?”
In her talk, she discussed the complex interaction between genetic factors and environmental influences in thyroid regulation.
Moreover, she highlighted the importance of understanding these mechanisms for improving diagnostics and patient care.

Secondly, Assist. Prof. Dubravka Brdar (KBC Split) gave an oral presentation entitled “Establishment of a Biobank of Patients with Thyroid Diseases: Integration of Laboratory and Clinical Data.”
She presented the first results of the InnoThyroGene project, explaining how combining laboratory findings with clinical data supports more precise research and future clinical applications.

Finally, Martina Domić, MD (KBC Split) presented a poster titled “Pharmacotherapy and Adherence in Patients with Thyroid Diseases.”
Her work offered preliminary insights based on data collected within the InnoThyroGene biobank.
In addition, it highlighted the importance of treatment adherence for achieving better outcomes in thyroid care.

Audience Engagement and Project Visibility

Throughout all three presentations, the InnoThyroGene project was clearly showcased.
As a result, the audience showed strong interest in the project’s goals, methods and early results.
After the sessions, many participants approached the presenters, asking questions and offering positive feedback.

This active engagement confirmed the relevance of the project within both professional and academic communities.

Impact of InnoThyroGene at the MLD Conference in Šibenik

The conference delivered several important outcomes for the project:

• Increased visibility of InnoThyroGene among healthcare professionals and academics
• Clear presentation of the clinical and research challenges addressed by the project
• Strong interest in the establishment and use of the thyroid disease biobank
• Positive feedback that confirmed the project’s scientific and practical value
• New opportunities for future collaboration and knowledge exchange

Consequently, InnoThyroGene at the MLD Conference in Šibenik strengthened its position as a relevant initiative in thyroid disease research and laboratory diagnostics.

Conclusion

The MLD conference in Šibenik demonstrated how coordinated clinical and research efforts can support the transformation of laboratory diagnostics.
By presenting genetics, biobanking and pharmacotherapy within a single framework, the speakers showed the real-world value of integrated research approaches.
Therefore, InnoThyroGene at the MLD Conference in Šibenik contributed to advancing professional dialogue and reinforcing the project’s long-term impact.

Stay Connected

For more updates on scientific events and project activities, follow InnoThyroGene on LinkedIn, X (Twitter), Facebook and Instagram.